Morbid (severe) obesity with alveolar hypoventilation 2016 2017 2018 2019 2020 2021 Billable/Specific Code E66.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM E66.2 became effective on October 1, 2020.
2016 2017 2018 2019 Billable/Specific Code. G47.34 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Idio sleep related nonobstructive alveolar hypoventilation.
G47.35 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM G47.35 became effective on October 1, 2021. This is the American ICD-10-CM version of G47.35 - other international versions of ICD-10 G47.35 may differ. nonorganic sleep disorders ( F51.-)
Hypoventilation syndrome in very obese persons with excessive adipose tissue around the abdomen and diaphragm. It is characterized by diminished to absent ventilatory chemoresponsiveness; chronic hypoxia; hypercapnia; polycythemia; and long periods of sleep during day and night (hypersomnolence).
G47. 36 - Sleep related hypoventilation in conditions classified elsewhere | ICD-10-CM.
Obesity hypoventilation syndrome is a respiratory consequence of morbid obesity that is characterized by alveolar hypoventilation during sleep and wakefulness. The disorder involves a complex interaction between impaired respiratory mechanics, ventilatory drive and sleep-disordered breathing.
The definitive test for diagnosing alveolar hypoventilation is room air arterial blood gas. However, simple tests to screen for OHS may aid clinicians and patients who may be reluctant to undergo an arterial puncture or in clinical scenarios when arterial blood gas analysis is not readily available.
Congenital central hypoventilation syndrome (CCHS) is a disorder that affects normal breathing. People with this disorder take shallow breaths (hypoventilate), especially during sleep, resulting in a shortage of oxygen and a buildup of carbon dioxide in the blood.
Definition. Primary alveolar hypoventilation is a rare disorder in which a person does not take enough breaths per minute. The lungs and airways are normal.
Hyperventilation — Alveolar hyperventilation is present when alveolar ventilation is increased out of proportion to carbon dioxide production and the arterial tension of carbon dioxide (PaCO2) decreases below the normal range (<36 mmHg, or <4.8 kPa).
Bronchodilators, such as beta agonists (eg, albuterol, salmeterol), anticholinergic agents (eg, ipratropium bromide), and methylxanthines (eg, theophylline), are helpful in treating patients with obstructive lung disease and severe bronchospasm.
The classic features of obesity hypoventilation syndrome (OHS) are obesity and daytime hypercapnia. The differences between OHS and obstructive sleep apnoea (OSA) are that the former has: Longer and more continuous episodes of hypoventilation overnight (there may or may not be upper airway obstruction).
Hypoventilation may be caused by: A medical condition such as stroke affecting the brainstem. Voluntary breath-holding or underbreathing, for example, hypoventilation training or the Buteyko method. Medication or drugs, typically when taken in accidental or intentional overdose.
Congenital central hypoventilation syndrome (CCHS), also known as “Ondine's curse,” is a rare neurological disorder characterized by inadequate breathing during sleep and in more severely affected individuals, during waking periods as well.
Respiratory acidosis involves a decrease in respiratory rate and/or volume (hypoventilation). Common causes include impaired respiratory drive (eg, due to toxins, CNS disease), and airflow obstruction (eg, due to asthma, COPD [chronic obstructive pulmonary disease], sleep apnea, airway edema).
Alveolar ventilation ( A) is defined as the volume of air entering and leaving the alveoli per minute.
htm. Obesity hypoventilation syndrome (OHS), can be a serious, but treatable, complication of being obese.
The symptoms of hypoventilation vary depending on the severity of the condition....Respiratory Depression SymptomsLethargy and tiredness.Daytime sleepiness.Slow and shallow breathing.Depression.Shortness of breath.
Causes of central alveolar hypoventilation include drugs and central nervous system (CNS) diseases such as cerebrovascular accidents, trauma, and neoplasms.
Incorporating elevated serum bicarbonate levels and/or low finger pulse oximetry may augment OHS screening among obese OSA patients. The overall prevalence of OHS is estimated to be approximately 0.6% of the general adult population.
Obesity hypoventilation syndrome (also known as Pickwickian syndrome) is a condition in which severely overweight people fail to breathe rapidly enough or deeply enough, resulting in low blood oxygen levels and high blood carbon dioxide (CO2) levels.
Inclusion Terms are a list of concepts for which a specific code is used. The list of Inclusion Terms is useful for determining the correct code in some cases, but the list is not necessarily exhaustive.
The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code E66.2. Click on any term below to browse the alphabetical index.
This is the official exact match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that in all cases where the ICD9 code 278.03 was previously used, E66.2 is the appropriate modern ICD10 code.
The ICD code G473 is used to code Sleep apnea. Sleep apnea, also spelled sleep apnoea, is a sleep disorder characterized by pauses in breathing or instances of shallow breathing during sleep. Each pause in breathing, called apnea, can last for several seconds to several minutes. By definition, more than five episodes an hour must occur.
Sleep apnea is often diagnosed with an overnight sleep test called a polysomnogram, or "sleep study". Specialty: